EX-23.1 2 tv479780_ex23-1.htm EXHIBIT 23.1

 

Exhibit 23.1

 

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the use in the Registration Statement on Form S-1 of our report dated June 29, 2017, except for notes 1, 2, 3, 10, 12, 13 and 17 which are as of December 21, 2017, relating to the consolidated financial statements of Bionik Laboratories Corp. consisting of the consolidated balance sheets as of March 31, 2017 and 2016, and the related consolidated statements of operations and comprehensive (loss) income, changes in shareholders’ equity (deficiency), and cash flows for the years ended March 31, 2017 and 2016.

 

Signed:

 

 

 

Toronto, Ontario

December 21, 2017